Crinetics Pharmaceuticals
CRNX
CRNX
50 hedge funds and large institutions have $503M invested in Crinetics Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
+1
Holders Change %
+2.04%
% of All Funds
1.12%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
10
Increased
17
Reduced
11
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
LCM
51
Laurion Capital Management
New York
| – | -$3.37M | -117,700 | Closed |
|
|
FCMI
52
Foresite Capital Management IV
Larkspur,
California
| – | -$1.42M | -49,600 | Closed |
|
|
MWNA
53
Marshall Wace North America
New York
| – | -$895K | -31,241 | Closed |
|
|
DIM
54
DC Investments Management
Mclean,
Virginia
| – | -$701K | -24,480 | Closed |
|
|
BCM
55
BlueCrest Capital Management
St Helier,
Jersey
| – | -$381K | -13,289 | Closed |
|
|
LCM
56
Landscape Capital Management
Englewood,
New Jersey
| – | -$341K | -11,893 | Closed |
|
|
ZP
57
Zimmer Partners
New York
| – | -$287K | -10,000 | Closed |
|
58
Barclays
London,
United Kingdom
| – | -$75K | -2,608 | Closed |
|
|
FIA
59
FNY Investment Advisers
New York
| – | -$57K | -2,000 | Closed |
|